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ABSTRACT: Aqueous root extract of Albizzia chevalieri has been reported to possess 
hypoglycaemic and hypolipidaemic effects. The current work investigated the LD50 of the crude 
aqueous root extract of Albizzia chevalieri and the effect of sub-chronic doses of the extract on liver 
and kidney function parameters of albino rats. The results indicated LD50 greater than 3000mg/kg 
body weight in albino rats observed for 72 hours. The result of the sub-chronic toxicity on liver 
function parameters showed significant (P<0.05) increase in serum total protein and globulin at 
doses greater than 2000mg//kg, which was reflected on the A:G ratio. Transaminases and alkaline 
phosphatase activities were also significantly (P<0.05) affected at doses greater than 2000mg/kg. 
Serum levels of urea were also increased significantly (P<0.05) but creatinine and uric acids were 
decreased significantly (P<0.05) at doses greater than 2000 mg/kg., Serum electrolytes were 
however not affected. The extract should therefore be use with care especially at doses greater than 
2000 mg/kg. 
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INTRODUCTION 
Herbal plants produce and contain a variety of 
chemical substances with varied physiological 
effects. They are huge reservoir of various 
chemical substances with potential therapeutic 
properties (Lewis and Elvin-Lewis, 1995). 
Herbal plants are being increasingly utilized to 
treat a wide variety of clinical diseases (Gupta 
et al., 2004).   
Herbs have been used by all cultures 
throughout history and thus, herbal medicine is 
the oldest form of health care known to 
mankind. It was an integral part of the 
development of modern civilization. Many 
drugs commonly used today are of herbal 
origin. Higher plants as source of medicinal 
compound continue to play a dominant role in 
maintenance of human health since antiquities 
(Suffness and Dowos 1982).  The primary 
benefit of using plant derived-medicine is that 
they are relatively safer than synthetic 
alternatives, offering profound therapeutic 
benefits and affordable treatment (Iwu, 1994).  
However, it must be noted that not all 
medicinal plants are safe for consumption in 
the crude form. Some level of toxicity may 
arise as a result of potential toxic compounds 
they contain and pesticide application during 
cultivation (Amdur et al., 1991 and Evans 
1999). The therapeutic properties of medicinal 
plants used by traditional medical practitioners 
may be due to one or more of the many 
compounds of the plant material. These 
phytochemicals include complex 
carbohydrates, alkaloids, glycopeptides, 
terpenoids, tannins, cyanogens, peptides and 
amines, steroids, flavonoids, lipids, coumarins, 
sulphur compounds and inorganic ions among 
numerous others. Some of these compounds 
may be toxic, and thus the plants containing 
them, when consumed could confer varied 
levels of toxicity to the individual (Humphrey 
and McKenna, 1997).  The growing interest in 
herbal medicine therefore demands toxicity 
risk assessment of the various indigenous 
preparations used in the treatment of diseases 
(Yakubu et al., 2005).  
The African continent is one of the continents 
endowed with the richest biodiversity in the 
world with food plants used as herbs, food and 
for therapeutic purposes (Iwu, 1994). One of 
such plants is Albizzia chevalieri (family 
Fabaceae). It is a large genus of tree, native to 
warm regions of the old world. It is usually 




small trees or shrubs that grow up to 6m, 
occasionally 12m, with an open and rounded 
or umbrella shaped canopy, bark pale-grayish, 
corky and deeply creviced, dark brown slash. 
Twigs pubescent with 20-40 pairs leaflets each 
(Houerou, 2006). The plant is found in 
Southern Sahel, Northern Sudan, Savannas of 
Senegal to Chad and in parts of Northern   
Nigeria.  
A. chevalieri leaves is widely used for the 
management of diabetes mellitus by traditional 
medicinal practitioners in some part of Nigeria 
and Niger Republic. Hypoglycaemic effects of 
the leaves (Saidu et al., 2007a) and root (Saidu 
et al., 2010) have been reported.  
The present study investigated the acute and 
sub-chronic toxicity effects of the crude 
aqueous root extract of A. chevalieri in rats. 
 
MATERIALS AND METHODS 
Chemical and Reagent: All the chemicals 
and reagents used for thes study were of 
analytical grade. Assay kits were purchased 
from Randox Laboratories Ltd, Antrim, United 
Kingdom. 
Plant Material: Fresh A. chevalieri root were 
obtain from Sanyinna, about 50km South of 
Sokoto, Nigeria. The plant material was 
identified by a Taxanomist in the Botany unit 
of the Department of the Biological Sciences, 
Usmanu Danfodiyo University Sokoto (UDUS) 
and voucher specimen were prepared and 
deposited in the Herbarium of the same 
Department. The root was dried in a shade, 
pulverized into a moderately coarse powder, 
using laboratory pestle and mortar and sieved 
with a 1mm
2
 sieve. The root powder was kept 
in a desiccator until required (Onoruvwe and 
Olorunfemi, 1998). 
Preparation of Crude Extract: The 
powdered plant material was soaked in cold 
distilled water for 24 hours, after which it was 
filtered using a piece of clean, sterile, white 
Muslin cloth to remove debris and then 
through Whatman No. 1 filter paper. The 
percentage recovery was determined and the 
extract labeled crude aqueous extract and 
stored in small, capped plastic container at 
+4
o
C until required. 
Experimental Animals:  Fifty five albino rats, 
weighing 100-130g age 10-12 weeks were 
purchased from National Veterinary Research 
Institute Vom Jos, Nigeria and used for the 
studies. The rats were housed in metal cages in 
the Research Laboratory of Biochemistry 
Department, UDUS and allowed to acclimatize 
for three weeks. The rats were maintained on 
standard rats chows (Neimeth Livestock feed, 
Ikeja, Nigeria) ad libitum and allowed free 
access to drinking water. 
Experimental procedure involving animals and 
their care were employed in conformity with 
guidelines for care and use of laboratory 
animals and the procedure approved by the 
Ethical Committee of UDUS, Nigeria.  
Acute Toxicity Studies: The limit test dose, 
up and down procedure of Organization for 
Economic and Cultural Development (OECD) 
(2001), was employed. Aqueous extract of the 
plant (3000mg/kg body weight) were 
administered to 5 rats (one after the other) in a 
single oral dose and observed for 72 hours. 
Another group of five rats (control) received 
distilled water. The rats were observed for 
toxic symptoms such as weakness, loss of 
appetite, difficulty in movement, reaction to 
noise, and mortality.  
Sub acute Toxicity Studies: A total of 25 
albino rats were randomly divided into 5 
groups of 5 rats each. Animals in groups 2, 3, 
4, and 5 were orally administered 750, 1500, 
2250 and 3000mg/kg body weight respectively, 
once daily for 28 days. Animals in Group 1 
served as control group and received distilled 
water through the same route. The body 
weights of all the rats were recorded weekly 
throughout the experimental period. After 28 
days of treatment the rats were fasted for 8 
hours and anaesthetized in chloroform vapour 
and blood sample collected by cardiac 
puncture for biochemical analyses.  
Determination of Biochemical Parameters:  
Serum total protein was determined by Biuret 
method as reported by Peter Jr. et al., (1982). 
Albumin was determined according to method 
of Doumas, et al., (1971) while globulin and 
A:G ratio were calculated. Aspartate 
Aminotranferase (AST) and Alanine 
Aminotransferase were estimated according to 
the method of Reitman and Frankel, (1957). 
Alkaline phosphatase was determined by 
Randox (Colorimetric) method of Rec (1972). 
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Bilirubin (Colorimetric method) was carried 
out according to method of Jendrasick and 
Grof, (1938) and Sherlock (1951). Urea was 
determined by the diacetylmonoxime method 
(Evans, 1968). Serum creatinine was estimated 
according to Jaffe’s Reaction (Butler, 1975). 
Uric Acid was estimated according to the 
method of Collin and Diehl (1959) and Morin 





determined using flame photometry method as 
described by the Jenway manual/data book and 
Uriyo and Singh (1974). Serum bicarbonate 
level was estimated by back titrimetric method 
of Vogel (1964). 
Statistical Analysis: Data were expressed as 
mean ± standard deviation (n=5). The results 
were analyzed using one way ANOVA. Post 
hoc was also conducted to determine the level 
of significant difference between each 
treatment and the control group using Tukey-
Kramer Multiple Comparisons Test. Test 
significant was considered at P < 0.05. 
 
RESULTS 
The experimental rats treated with acute dose 
of 3000 mg/kg body weight of the root extract 
of A. chevalieri displayed no appreciable 
change in physical activity and displayed no 
apparent toxicity symptoms or mortality up to 
72 hours post treatment, indicating that the 
LD50 of the crude extract in rats is greater than 
3000 mg/kg. 
Weekly weight changes of rats treated with 
sub-chronic doses showed that the extract did 
not affect growth of the rats significantly 
(P>0.05) (Table 1).  
Liver Function: The result of serum total 
protein showed that, the extract caused gradual 
increase as the dosage increases from 
750mg/kg to 3000mg/kg. Serum globulin also 
increased significantly (P<0.05) at high doses 
while the A:G ratio decreased significantly 
(P<0.05) as the doses increase (Table 2).  
Activities of  serum aspartate aminotransferase, 
alanine aminotransferase and alkaline 
phosphatase were affected at high doses (Table 
3). The root extract significantly (P<0.05) 
increased the serum levels of bilirubin at high 
doses. The increase is more prominent in the 
unconjugated bilirubin (Table 4). 
Kidney Function: Serum urea level of the 
rats treated with aqueous root extract of A. 
chevalieri  were significantly (P<0.05) 
increased while serum creatinine and uric 
acid levels were decreased at high doses 
(Table 5). The electrolytes were however 
not affected by the extract (Table 6). 
Table 1: Weekly weight changes (g) of rats administered different sub-chronic doses of aqueous 
root extract of A. chevalieri. 
  Weeks 
Group Initial weight 1  2  3 4 
Control 182.10±22.03 183.00±8.98 182.75±20.89  186.25±0.96  195.00±5.72 
750mg/kg 180.00±19.03 188.75±29.58 193.00±14.79 195.00±24.35 196.25±25.46 
1500mg/kg 181.70±40.30 185.00±31.32 185.75±13.45 189.25±11.93 196.25±4.03 
2250mg/kg 182.60±6.50 183.50±11.73 185.50±15.59 186.25±11.62 196.50±20.89 
3000mg/kg 168.00±29.80 171.25±26.13 175.00±24.35 176.00±24.17 188.75±27.65 
Values are expressed as mean ± Standard deviation of 5 rats treated for 28 days. 
 
Table 2: Serum proteins (g/dl) and albumin:globulin (A:G) ratio of rats treated with crude extract of A. 
chevalieri root for 28 days. 
Group  Protein* Albumin Globulin* GA : *  
Control 6.29±0.20 3.06±0.07   3.03±0.21 1.01±0.37 
750mg/kg 6.55±0.27 3.38±0.03    3.16±0.25 1.08±0.08 

















Values are expressed as mean ± Standard deviation of  5 rats.;* ANOVA indicated p<0.05; a values are significantly (P<0.05) different from the 
respective control   
Table 3: Some serum enzymes activities (U/L) of rats treated with crude aqueous extract of A. chevelieri 
root for 28 days. 
Group  Aspartate Aminotransferase*  Alkaline Phosphatase* Alanine Aminotransferase* 
0.00mg/kg 55.81±0.13 60.67±3.38 17.60 ± 0.44 
750mg/kg 60.74 ± 0.24 85.31 ± 3.68
a
 20.88 ± 0.51 
1500mg/kg 63.12 ± 0.70 102.12 ± 1.95
 a
  24.27 ± 0.55
 a
 
2250mg/kg 64.49 ± 1.26 109.85 ± 2.31
 a
 27.40 ± 0.55
 a
 
3000mg/kg 88.66 ± 0.29
a
 117.58 ± 3.15
 a
 39.00 ± 0.53
 a
 
Values are expressed as mean ± Standard deviation of 5 rats.;* ANOVA indicated p<0.05; a values are significantly (P<0.05) different from the 
respective control   
 
Table 4: Serum Bilirubin (µmol/l) levels of rats treated with crude aqueous extract of A. 
chevalieri root for 28 days. 
Group Total Bilirubin *    Direct Bilirubin  Unconjugated Bilirubin  * 
0.00mg/kg 17.71± 2.06         13.69 ±1.01     4.02±2.49 
750mg/kg 16.73± 1.10         11.84± 1.00 4.89±1.15 
1300mg/kg 15.14 ±1.18         10.73± 0.83 4.41±1.32 
2250mg/kg 20.66 ±1.35
a





      9.99 ±1.01 11.66±1.16
 a
  
Values are expressed as mean ± Standard deviation of 5 rats.;* ANOVA indicated p<0.05; a values are significantly (P<0.05) different from the 
respective control   
 
Table 5: Some Kidney function parameters of rats treated with crude aqueous root extract of A. 
chevalieri  for 28 days. 
Group Urea(µmol/l)* Creatinine(µg/dl)* Uric acid(mg/dl)* 
Control 6.36 ±0.55          276.11± 4.22            3.30±0.05             
750mg/kg 7.35±0.17
a




         
1500mg/kg 7.78± 0.22
 a




         
2250mg/kg 8.89± 0.13
 a




         
3000mg/kg 9.72± 0.23
 a
     163.89 ±4.39
 a
     1.09±0.03
 a
      
Values are expressed as mean ± Standard deviation of 5 rats.;* ANOVA indicated p<0.05; a values are significantly (P<0.05) different from the 
respective control. 
 
Table 6 Serum Electrolyte levels (mmol/l) of rats treated with crude aqueous extract of A. chevalieri 
root 28days. 
Group Sodium Potassium Bicarbonate* 
Control   149.80± 0.84 6.12±0.58 27.40±0.55 
750mg/kg   148.00± 1.00 5.90±1.00      26.00±0.71 
1500mg/kg   147.20 ±1.10 5.68±0.08 23.40±0.55 
2250mg/kg 146.60± 0.55 5.82±0.08    24.80±1.30 
3000mg/kg 145.60± 0.54 5.64±0.11 22.40±1.14a  




The root extract of A. chevalieri have been 
reported to possess significant hypoglycaemic 
and hypolipidaemic effects in alloxan induced 
diabetic rats (Saidu et al., 2010). It is however 
an established fact that some plant extracts could 
be inherently dangerous, containing naturally 
occurring toxins which may be cytotoxic 
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(Humphrey and McKenna, 1997).  Accordingly 
most of the herbal preparations do not have drug 
regulatory approval to demonstrate their safety 
and efficacy (Seth and Sharma, 2004).  It is 
therefore pertinent to establish the safety of 
medicinal plant preparations through 
toxicological assessments. Liver, being the 
primary organ for the detoxification and 
distribution of drugs, and the kidney, the major 
excretory organ, could be assessed to establish 
the safety of a substance (Guptan et. al, 1994).  
The result of the current study showed that the 
LD50 of the crude aqueous extract of the plant 
was found to be greater than 3000mg/kg, which 
may be accepted as safe (OECD 2001). Other 
workers have reported different LD50 values for 
different plant extracts. The oral (rat) LD50 of 
ethanol extract of Vitex leucoxylon leaf 
(>3000mg/kg), cold water infusion extract of the 
same plant (1050mg/kg), ethanolic extracts of 
Ailanthus excelsa (1000mg/kg), Toddalia 
asiatica  (350mg/kg) and Araucaria bidwilli 
(250 mg/kg) have been reported (Dahanukar et. 
al, 2000). The LD50 of Boerhavia diffusa has 
been reported to be >2000mg/kg body weight in 
both mice and rats (Orisakwe et. al, 2003). A. 
chevalieri leaf extract was also reported to be 
greater than 3000 mg/kg in rats (Saidu et al., 
2007b) 
In the current work there was a progressive 
increase in the body weights of the rats treated 
with different subchronic doses of the root 
extract of A. chevalieri.  This may be an 
indication that the drug does not affect the feed 
utilisation ratio of the animals. The body 
weights of animals treated with sub-chronic 
doses of aqueous extracts of Boerhavia diffusa 
(Orisakwe et. al, 2003) and A. chevalieri leaf 
(Saidu et al., 2007b) were also reported to 
increase progressively.  
Increased plasma total protein concentration 
observed in the current work at high doses may 
be due to dehydration and/or increased plasma 
immunoglobulin concentration due to infection. 
Accordingly, serum globulin concentration and 
albumin:globulin ratio were significantly 
(p<0.05) affected. This may be an indication that 
higher doses of the extract might have 
predisposed the animals to infection resulting in 
increased serum globulin and a decreased A:G 
ratio. 
The enzymes, Aspartate Aminotranferase (AST), 
Alanine Aminotransferase (ALT) and Alkaline 
Phosphatase (ALP) showed progressive increase 
in activities at all doses administered, with most 
significant effect at the 3000mg/kg. These 
findings imply that the extract, may at these 
doses, affect the liver. Serum ALT and AST are 
useful indices for identifying inflammation and 
necrosis of the liver (Tilkian et. al, 1979). ALT 
has its highest concentration in the liver with 
kidney and skeletal muscles having lesser 
activity of the enzyme. ALT measurements are 
however more liver specific than the AST and 
its activity is usually greater than AST activity at 
early or acute hepatocelluar disease (Whitby et. 
al, 1989). AST on the other hand tend to be 
released more than the ALT in chronic liver 
diseases such as cirrhosis (Whitby et. al, 
1989).Liver, bone placenta and intestine are 
clinically important sources of the plasma 
activity of ALP. The activity of this enzyme is 
increased in many clinical states; the most 
important being bone and liver diseases. 
Accordingly, serum ALP is a useful diagnostic, 
screening and follow up tools of cholestatic 
hepatobiliary lesions (Wolf, 1978). Cholestasis 
is the main, if not the only liver disease 
responsible for increased plasma alkaline 
phosphatase activity. Thus, a normal alkaline 
phosphatase activity, in the presence of 
abnormal levels of other liver function 
parameters, may be suggestive of liver 
pathology other than obstruction (Tilkian et. al, 
1979).  
Elevated Bilirubin is an indication of liver cell 
impairment. The gradual increase in the serum 
levels of Unconjugated Bilirubin may be an 
indication that there the rats had liver function 
impairment, resulting in diminished ability of 
hepatocytes to conjugate bilirubin. Bilirubin is a 
useful index of the excretory function of the 
liver. In the liver, bilirubin is conjugated with 
glucoronic acid in a reaction catalysed by 
bilirubin –UDP-glucuronyltransferase which 
renders it soluble and subsequently excreted into 
the bile. 
The extract of the root of A. chevalieri causes a 
significant increase in serum urea without 
adversely affecting the serum levels of uric acid, 
creatinine or the electrolytes. This may be 
indicative that the extract may have no any 
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adverse effect on the kidney. This assertion may 
be due to the fact that creatinine is usually a 
more accurate marker of kidney function than 
urea. Although elevated levels of creatinine, 
urea and uric acid are positive risk of renal 
impairment. A lower blood level of creatinine 
does not indicate impairment. The increased in 
serum urea levels recorded in the present study 
may be due to factors other than kidney problem 
(Baker et al., 2001).   
Although the root extract have been reported to 
possess significant hypoglycaemic effect in 
alloxan induced rats (Saidu et al., 2010), the 
results of the sub-chronic effect on the liver 
function parameters indicated that the root 
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